Ferozsons Laboratories Limited (PSX:FEROZ)

Ferozsons Laboratories Revenue

Ferozsons Laboratories had revenue of 7.07B PKR in the quarter ending September 30, 2026, with 19.11% growth. This brings the company's total for the last twelve months to 25.09B, up 23.81% year-over-year. In the fiscal year ending June 30, 2026, Ferozsons Laboratories had annual revenue of 23.96B with 27.05% growth. That makes Ferozsons Laboratories the 23,421st largest company in the world by revenue and 149th in Pakistan.

• Revenue (ttm): 25.09B
• Revenue Growth: +23.81%
• P/S Ratio: 0.63
• Revenue / Employee: 14.97M
• Employees: 1,676
• Market Cap: 15.55B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Ferozsons 15.76B 60.1%
• BF Biosciences 9.46B 36.1%
• Others 980.81M 3.7%

By Geography

Chart

• Pakistan 22.88B 95.5%
• Sri Lanka 418.45M 1.7%
• Afghanistan 210.90M 0.9%
• Others 151.83M 0.6%
• Myanmar 93.63M 0.4%
• Philippines 89.47M 0.4%
• Kenya 44.32M 0.2%
• Other 70.06M 0.3%

Fiscal year ended Jun 30, 2026 See the full Ferozsons Laboratories breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	23.96B	5.10B	27.05%
Jun 30, 2025	18.86B	3.00B	18.94%
Jun 30, 2024	15.85B	4.40B	38.38%
Jun 30, 2023	11.46B	2.13B	22.80%
Jun 30, 2022	9.33B	450.80M	5.08%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error